Catalysts for $COGT
6 tracked
May 5, 2026
earnings
Cogent Biosciences, Inc. earnings
Cogent Biosciences, Inc.
→
Nov 10, 2025
approval
YUSIMRY (ADALIMUMAB-AQVH) — FDA approval
YUSIMRY
→
Sep 13, 2023
approval
YUSIMRY (ADALIMUMAB-AQVH) — FDA approval
YUSIMRY
→
Mar 31, 2023
approval
YUSIMRY (ADALIMUMAB-AQVH) — FDA approval
YUSIMRY
→
Feb 27, 2023
approval
YUSIMRY (ADALIMUMAB-AQVH) — FDA approval
YUSIMRY
→
Dec 17, 2021
approval
YUSIMRY (ADALIMUMAB-AQVH) — FDA approval
YUSIMRY
→